论文部分内容阅读
目的：探讨妊娠合并甲状腺功能亢进（以下简称甲亢）的围产期预防及处理。方法：对８４３６例妊娠中合并甲亢患者１８例（０．２１％ ）的临床资料进行综合分析。结果：１８ 例中１６ 例孕前，２例孕后２ 个月～３ 个月诊断合并甲亢，均经抗甲状腺药物有效控制症状后继续妊娠。发生早产２例，妊高征５ 例，自然分娩１２ 例，产钳２例，剖宫产４ 例，新生儿甲状腺机能减退１ 例，无胎儿畸形及新生儿死亡病例，无甲亢危象。结论：加强围产期监测，积极控制妊高征和预防早产，以及甲亢症状的有效控制是确保孕妇围产期安全和胎儿正常生长发育的关键。
Objective: To investigate the perinatal prevention and treatment of pregnancy complicated with hyperthyroidism (hereinafter referred to as hyperthyroidism). Methods: A total of 8436 pregnant women with hyperthyroidism in 18 cases (0.21%) of the clinical data were analyzed. Results: In 18 cases, 16 cases were diagnosed before pregnancy and 2 cases were diagnosed with hyperthyroidism after 2 months to 3 months after pregnancy. All patients were treated with antithyroid drugs to control the symptoms and continue the pregnancy. There were 2 cases of premature delivery, 5 cases of pregnancy induced hypertension, 12 cases of spontaneous labor, 2 cases of forceps, 4 cases of cesarean section, 1 case of neonatal hypothyroidism, no fetal malformations and neonatal deaths, no hyperthyroidism crisis. Conclusion: To strengthen perinatal monitoring, to actively control pregnancy-induced hypertension and prevent preterm birth, as well as effective control of hyperthyroidism symptoms is to ensure that pregnant women, perinatal safety and fetal growth and development of the key.